Cantor Fitzgerald Begins Coverage on Amgen (NASDAQ:AMGN)

Cantor Fitzgerald Begins Coverage on Amgen (NASDAQ:AMGN)

Cantor Fitzgerald began coverage on shares of Amgen (NASDAQ:AMGN – Free Report) in a research report sent to investors on Tuesday, Marketbeat.com reports. The brokerage issued a neutral rating and a $305.00 price target on the medical research company’s stock. Cantor Fitzgerald also issued estimates for Amgen’s FY2025 earnings at $20.50 EPS. A number of […]

Cantor Fitzgerald Predicts Amgen FY2025 Earnings

Amgen Inc. (NASDAQ:AMGN – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Amgen in a report released on Tuesday, April 22nd. Cantor Fitzgerald analyst C. Gould expects that the medical research company will post earnings per share of $20.50 for the year. Cantor Fitzgerald has a “Neutral” rating […]